INTRODUCTION
Over the past three decades a significant increase in the incidence of multiple gestations has been observed. This phenomenon is a consequence of widely used ART (artificial reproductive techniques) including induction of ovulation and in vitrofertilization (IVF) but also due to the trend of late maternity. (1-4) Multifetal gestation brings a higher risk of maternal complications during pregnancy and postnatal complications for the babies, which are usually born prematurely. The risk of preterm delivery for triplet pregnancies is approximately 90% while in twin gestations is more than 50%, compared with only 10% of preterm births of single infants. (5, 6) The rate of preterm births before 32 weeks of gestation in triplets is 3.3-fold higher than in twins and 24.1-fold higher than in singletons. (1) A marked improvement of care for mothers with multiple pregnancies in specialized centers of perinatal care and early identification of risk factors for preterm delivery as well as significant progress in neonatal intensive care have contributed to increased survival and reduced morbidity of premature newborns. However, as shown in previous publications, it seems that this improvement is not significant in the case of children coming from triplet pregnancies. (1,2) Therefore, the aim of our retrospective study was to compare respiratory disorders (respiratory distress syndrome, requirement for respiratory support, development of chronic lung disease), duration of hospitalization and other neonatal outcomes of triplet pregnancies over a 10 year period to detect any progress in this area and to compare the outcomes and the incidence of complications between the two groups of premature newborns: born from triplet pregnancies between 2006 to 2011 and between 2012 and 2015.
MATERIAL AND METHODS
This retrospective study was conducted in one tertiary perinatal center in Poland. The study population consists of 34 sets of triplets delivered over a period of ten years -between 2006 and 2015. Pregnancy history and neonatal data were obtained from medical records in the hospital database. Ninety-nine newborns from these pregnancies were divided into 2 groups: group I consisted of 56 live-born neonates (19 sets of triplets) born between 2006 and 2011 and group II consisted of 43 live-born infants delivered from 15 triplet pregnancies between 2012 and 2015. For both groups we analyzed the following parameters: maternal age, gestational age, birth weight, gender, 1st and 5th minute Apgar score as well as respiratory disorders like: respiratory distress syndrome (RDS), chronic lung disease (CLD), requirement and duration of respiratory support, type of respiratory support: invasive (mechanical ventilation via endotracheal tube) and non-invasive (nCPAP -nasal continuous positive airway pressure, SIPAP etc), surfactant administration and complications including retinopathy of prematurity (ROP) stage > 2 and intraventricular hemorrhage (IVH) of III and IV grade. Duration of hospitalization and mortality rate were also compared. Gestational age (g.a.) was calculated from the data of the last menstrual period in SIGNA VITAE 2017; 13(2): 76-78 spontaneously conceived pregnancies or from the data of embryo transfer for the IVF gestations. RDS was diagnosed based on clinical picture and chest x-ray. Surfactant was administered routinely to all infants born before 28th week of gestation, for infants delivered after 28th week g.a. only if they required intubation for RDS and if their oxygen requirement was more than 0.4. Chronic lung disease was defined as dependence on supplemental oxygen at the corrected g.a. of 36 weeks. Diagnosis of retinopathy of prematurity was raised by the consultant ophthalmologist after examination of the fundus. IVH was diagnosed by head ultrasound performed in all premature newborns in the neonatal invasive care unit (NICU). For each parameter, the mean, median, standard deviation, lower and upper quartiles and range were calculated. Statistical significance between means for different groups was calculated by one-way analysis of variance (ANOVA), alternatively using the non-parametrical Kruskal-Wallis test, when the variances in groups were not homogeneous (the homogeneity of variance was determined by the Bartlett's test). Statistical significance between frequencies was calculated by the chi-square test with Yate's correction or if expected value was less than 5, by Fisher exact test. A p value of less than 0.05 was considered statistically significant. Statistical analysis was performed using EPIINFO Ver. 7.1.1.14 software package.
RESULTS
The mean gestational age for group I was 32.5 ± 2 weeks (M ± SD) (min. 27 to max. 35 weeks g.a.) and for group II was 32. The mean mothers' age did not differ significantly between groups (30.7 ± 3.9 for group I vs. 30.9 ± 4.6 for group II, ANOVA test p=0.785). We did not observe a statistically significant difference between both groups in Apgar score at 1 minute (6.85 ± 1.63 for first vs 6.84 ± 1.72 for second group, Kruskal-Wallis test p=0,900), only at the 5th minute the Apgar score for group II was significantly higher (7.04 ± 1.48 for group I vs 7.79 ± 1.19 for group II, p=0,0197 as calculated by KruskallWallis test). Over the years, the incidence of severe respiratory insufficiency due to RDS (16 cases in first group vs. 6 cases in second group, the result of chi-square test with Yate's correction was Χ2=2,22 and p=0.136) or CLD (6 cases in group I vs. 1 case in group II, Fisher test calculated p=0.134F) did not change significantly, as well as the incidence of intraventricular hemorrhage (III and IV grade) (7 cases in first group, 5 cases in second, the result of chi-square test with Yate's correction was Χ2=0,032 and p=0,858) and retinopathy of prematurity (5 cases in group I, 3 in group II, Fisher test p=0.999F). Three babies died in group I, while in group II one death was reported, which was not statistically significant (Fisher test p=0,631F) (table 1).
DISCUSSION
In the past decades, neonatology has become one of the most dynamically developing fields in medicine. Milestones such as prenatal corticosteroids for fetal lung maturation, intra-tracheal surfactant administration for RDS, new methods of ventilation including high frequency ventilation, non-invasive ventilation, inhaled nitric oxide (iNO) for the treatment of pul- 
